Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. Company
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Euronext Paris  -  06:22 2022-12-05 am EST
85.78 EUR   +0.01%
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/02Weekly market update : One step forward, one step back
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (71.5%): prescription drugs in the areas of general medicine (52.7% of net sales; mainly for the treatment of diabetes and cardiovascular diseases) and specialty medicine (47.3%; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases);

- human vaccines (16.7%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;

- consumer health products (11.8%).

At the end of 2021, the group had 67 production sites throughout the world.

Net sales are distributed geographically as follows: France (6%), Europe (19.8%), the United States (38.1%), China (7.2%), Japan (4.4%), Brazil (2.2%), Russia (1.5%) and other (20.8%).

Number of employees : 95 442 people.
Sales per Business
20202021Delta
Pharmaceuticals25 674.0071.2%26 970.0071.4% +5.05%
Vaccines5 973.0016.6%6 323.0016.7% +5.86%
Consumer Healthcare4 394.0012.2%4 468.0011.8% +1.68%
EUR in Million
Sales per region
20202021Delta
United States13 465.0037.4%14 385.0038.1% +6.83%
Rest of the World7 759.0021.5%7 850.0020.8% +1.17%
Europe6 928.0019.2%7 503.0019.9% +8.3%
China2 454.006.8%2 720.007.2% +10.84%
France2 223.006.2%2 256.006% +1.48%
Japan1 735.004.8%1 657.004.4% -4.5%
Brazil836.002.3%815.002.2% -2.51%
Russia641.001.8%575.001.5% -10.3%
EUR in Million
Managers
Name Title Age Since
Paul Hudson Chief Executive Officer & Director 55 2019
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President 57 2018
John Reed EVP & Global Head-Research & Development 64 -
Nestle Frank Global Head-Immunology Therapeutic Research Area - 2016
Dietmar Berger Chief Medical Officer & Global Head-Development - -
Eva Schäfer-Jansen Investor Relations Contact - -
Olivier Antoine M. Charmeil Executive Vice President-General Medicines 57 -
Arnaud Robert, Dr. Chief Digital Officer & Executive Vice President - 2020
Julie van Ongevalle Executive VP & Head-Consumer Healthcare - 2020
William J. Sibold EVP-Specialty Care & President-North America - -
Members of the board
Name Title Age Since
Serge Weinberg Director 71 2009
Fabienne Lecorvaisier Independent Director 60 2013
Patrick Kron Independent Director 69 2014
Diane D. Souza Independent Director 70 2016
Thomas C. Südhof, Dr. Independent Director 66 2016
Rachel Duan Independent Non-Executive Director 52 2020
Lise Kingo Independent Director 61 2020
Gilles Schnepp Independent Director 63 2020
Barbara Lavernos Independent Director 53 2021
Carole Ferrand Independent Director 51 2022
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,265,431,967 1,112,376,732 87.9% 13,430,000 1.1% 87.9%
Shareholders
NameEquities%
L'Oréal S.A. 118,227,307 9.33%
Dodge & Cox 63,444,721 5.01%
The Vanguard Group, Inc. 30,688,247 2.42%
Norges Bank Investment Management 25,527,770 2.01%
Amundi Asset Management SA (Investment Management) 23,532,259 1.86%
FIL Investment Advisors (UK) Ltd. 12,478,586 0.98%
BlackRock Advisors (UK) Ltd. 11,383,289 0.90%
BlackRock Investment Management (UK) Ltd. 10,774,363 0.85%
BlackRock Investment Management LLC 9,755,851 0.77%
Franklin Advisers, Inc. 9,482,014 0.75%
Holdings
NameEquities%Valuation
SANOFI INDIA LIMITED (500674) 13,909,587 60.4% 943,159,994 USD
EUROAPI (EAPI) 28,298,074 29.9% 495,180,639 USD
ICOSAVAX, INC. (ICVX) 3,155,169 7.91% 10,822,230 USD
CLOUDR GROUP LIMITED (9955) 3,860,600 0.66% 8,783,637 USD
Markets and indexes
- PEA / SRD eligible : YES / YES
- Compartiment A
- CAC 40 / CAC 40 ESG, CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, Euro Stoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, SBF 120, Stoxx Europe 50, STOXX Europe 600, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  
Company contact information
Sanofi
46 Avenue de la Grande Armée
FR-75017 Paris

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
web site : https://www.sanofi.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sanofi
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
SANOFI-3.17%112 783
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY35.67%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
PFIZER, INC.-13.78%285 774
MERCK & CO., INC.43.58%278 995
ROCHE HOLDING AG-18.69%270 669
ASTRAZENECA PLC28.81%212 164
NOVARTIS AG4.81%192 650
BRISTOL-MYERS SQUIBB COMPANY30.12%180 080
AMGEN INC.26.91%152 342
GILEAD SCIENCES, INC.22.61%111 665
GSK PLC-13.36%70 368
DAIICHI SANKYO CO., LTD.50.60%62 399
BAYER AG16.68%56 492
TAKEDA PHARMACEUTICAL COMPANY LIMITED26.46%45 571
CHUGAI PHARMACEUTICAL CO., LTD-4.42%43 395
JIANGSU HENGRUI MEDICINE CO., LTD.-20.13%36 798
ASTELLAS PHARMA INC.11.44%28 074
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-2.70%23 768